Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Paying it Forward: Empowering Career Migration Journeys

Healthcare leaders discuss how mentorship programs and personal immigration experiences can create meaningful career pathways for internationally trained professionals entering the U.S. healthcare workforce. The conversation highlights the role of paying it forward as a driving principle among those who have navigated career migration themselves.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

By Lea Sims · AiAmnCareerCgfns
Share

Key takeaways

01

Mentorship from those with lived immigration experience is a key enabler for internationally trained healthcare professionals.

02

Personal career migration stories provide authentic guidance and reduce barriers for newcomers seeking U.S. roles.

03

Healthcare organizations benefit from actively supporting internationally trained talent as part of workforce development strategies.

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

On the latest episode of Care Anywhere: The Global Health Workforce Podcast, host Lea Sims sits down with Sinead Carbery, President of International Staffing Solutions, and Gillian Williams, MSN, BS, RN, Senior Director of Clinical Operations, both from AMN Healthcare. The episode delves into the complexities of global career mobility for healthcare professionals, with Sinead and Gillian sharing their personal experiences as internationally educated nurses who transitioned to the U.S. in search of opportunity.

Sinead, originally from Ireland, and Gillian, from Trinidad, describe the challenges they faced when moving their careers across borders. For Sinead, the journey was an adventure shaped by economic challenges in Ireland and the steep learning curve of adapting to new clinical practices in the U.S. Gillian's migration was driven by a lack of career mobility in Trinidad, where advancement opportunities were rare. Both emphasized the importance of adaptability, self-care, and building support networks to thrive in a new healthcare system.

Both emphasized the importance of adaptability, self-care, and building support networks to thrive in a new healthcare system.

Now leaders in international recruitment, Sinead and Gillian are passionate about helping others navigate similar journeys. Sinead, a CGFNS Daisy Award honoree for Ethical Recruitment, shared how AMN Healthcare prioritizes transparency and fairness, ensuring clinicians are supported both professionally and personally. She highlighted that ethical recruitment goes beyond job placement, extending to helping healthcare workers and their families adjust to life in a new country.

Ethical recruitment goes beyond job placement, extending to helping healthcare workers and their families adjust to life in a new country.

Reflecting on the rapidly evolving healthcare landscape, Sinead and Gillian noted the increasing importance of technology, such as telehealth and AI, and the need for a growth mindset among clinicians. They emphasized that global career mobility is often about more than economics—it's about creating better opportunities for families and advancing professional aspirations.

Follow Along For More Episodes!

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

LS
Lea Sims
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended AstraZeneca and Daiichi Sankyo’s Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly is investing $6.5 billion in a Houston manufacturing facility set to open around 2030, primarily to scale production of Foundayo, its oral GLP-1 treatment. The project signals a broader shift in U.S. pharmaceutical manufacturing reshoring and underscores the supply chain challenge of forecasting demand and building capacity years in advance for breakthrough therapeutics.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain: Lilly's CEO noted that one-third of new GLP-1 pill patients are now choosing Foundayo, illustrating fast-moving market share shifts that complicate production planning years in advance
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

Waiting for perfectly clean data is stalling healthcare AI, not protecting it

Healthcare organizations often delay AI initiatives waiting for perfectly clean data, but this assumption no longer holds: reliable subsets and synthetic data allow projects to start now while data work continues in parallel. Success requires starting with business outcomes rather than technology capabilities, and embedding governance in product strategy before implementation, not after.

  • 01Waiting for 100% clean data is effectively a decision never to start; hospital AI projects can begin on reliable data subsets while quality work continues in parallel.
  • 02Frame AI decisions around business outcomes (revenue growth, cost reduction, competitive advantage, new products, or ecosystem influence) rather than asking what AI can do.
  • 03Governance should be part of product strategy before design or purchase, especially as agentic AI takes actions—such as handling many revenue-cycle denials—while routing the rest to humans.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Expert

LS
Lea Sims

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512